Immunome stockholders elect Barchas and Bienaimé as Class II directors; ratify Ernst & Young

Immunome Inc.

Isaac Barchas elected with 46.3M votes for, 15.2M withheld; Jean-Jacques Bienaimé elected with 47.1M for, 14.4M withheld.
Stockholders ratified Ernst & Young as auditor for FY2025 with 76.3M votes for, 16K against.
Broker non-votes totaled 14.7M on both director proposals; none on auditor ratification.
Meeting held June 10, 2025; 87,011,822 shares outstanding and entitled to vote as of April 21 record date.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.